MiMedx Group, Inc.
MDXG
$7.08
-$0.23-3.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.07% | 4.13% | 7.00% | 2.87% | 7.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.07% | 4.13% | 7.00% | 2.87% | 7.32% |
| Cost of Revenue | 25.76% | 27.50% | 22.16% | 3.60% | 9.36% |
| Gross Profit | 10.47% | -0.10% | 4.12% | 2.71% | 6.91% |
| SG&A Expenses | 40.37% | 8.17% | 11.32% | 3.11% | -13.73% |
| Depreciation & Amortization | -47.37% | -47.62% | 0.52% | 1.05% | -0.52% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.26% | 11.89% | 14.60% | 2.85% | -9.46% |
| Operating Income | -47.25% | -37.74% | -28.03% | 3.02% | 116.35% |
| Income Before Tax | -43.97% | -24.52% | -19.15% | 21.05% | 152.98% |
| Income Tax Expenses | -39.43% | -32.33% | 110.20% | 499.15% | 7,660.81% |
| Earnings from Continuing Operations | -45.42% | -22.49% | -85.50% | -10.90% | 90.48% |
| Earnings from Discontinued Operations | -- | -- | -100.00% | 170.45% | 100.05% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.43% | -24.17% | -86.09% | -5.14% | 1,368.75% |
| EBIT | -47.25% | -37.74% | -28.03% | 3.02% | 116.35% |
| EBITDA | -36.88% | -18.14% | -13.23% | 5.41% | 110.17% |
| EPS Basic | -45.57% | -24.64% | -87.15% | -5.16% | 2,700.00% |
| Normalized Basic EPS | -44.16% | -33.52% | -33.79% | -1.78% | 98.99% |
| EPS Diluted | -49.83% | -22.19% | -86.13% | -9.65% | 1,358.54% |
| Normalized Diluted EPS | -44.15% | -32.84% | -19.08% | 25.38% | 149.10% |
| Average Basic Shares Outstanding | 0.30% | 0.59% | 23.16% | 26.36% | 27.15% |
| Average Diluted Shares Outstanding | 0.28% | -0.23% | 0.79% | -0.93% | 1.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |